vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)

Q: What does CUSIP 918385204 represent in this 13F holders report?

CUSIP 918385204 is the security identifier for VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share in Q3 2023?

1 institutional investor reported VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 918385204

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Class A Common Stock, par value $0.01 per share
Total 13F shares: 600
Total 13F value: $287
Share change: +600
SEC-reported price per share: $0.48
Number of holders: 1
Value change: +$287
Number of buys: 1
Shares outstanding: 3,911,217

Security key

918385204

Report period

Q3 2023

Institutions

Top holders

VTVT full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 vTv Therapeutics Inc. SEC filings vTv Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 918385204

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Ronald O Perelman

Disclosed value leader

Ronald O Perelman

Comparable rows

0/15

Latest evidence

30 Jun 2023

3/4/5 13F Highest disclosed value: $30,482,586 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Ronald O Perelman has the largest disclosed position value at $30.48M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ronald O Perelman's linked filing trail.

Disclosed position value Top 5

Ronald O Perelman $30.48M

Deepa Prasad $29.51M

Rich S. Nelson $5.9M

Samsara BioCapital, LLC $1.21M

Chandresh Harjivan $1.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Ronald O Perelman	3/4/5 10%+ Owner 3/4/5	— class O/S missing	$30,482,586 36,519,212 shares	—	20 Dec 2021
G42 Investments AI Holdings RSC Ltd.	3/4/5 Director, 10%+ Owner 3/4/5	— class O/S missing	— 10,386,274 shares	—	31 May 2022
Hh Sheikh Tahnoon bin Zayed S. Al-Nahyan	3/4/5 10%+ Owner 3/4/5	— class O/S missing	— 10,386,274 shares	—	31 May 2022
Deepa Prasad	3/4/5 President and CEO, Director 3/4/5	— class O/S missing	$29,508,879 2,498,635 shares	—	19 Oct 2021
Rich S. Nelson	3/4/5 Acting Chief Executive Officer, Director 3/4/5	— class O/S missing	$5,905,000 500,000 shares	—	03 Mar 2022
Samsara BioCapital, LLC	13F Company 13F	— class O/S missing	$1,209,950 1,635,509 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

600

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q1 2026 Across Filers

Q1 2026 holders

Q3 2023 holders

Holder diff

-34

Investor	Q1 2026 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q1 2026 value	Q3 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend